Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Cardiomyopathies » Cardiomyopathy, Hypertrophic
Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Heart Valve Diseases » Aortic Valve Disease » Aortic Valve Stenosis » Aortic Stenosis, Subvalvular » Cardiomyopathy, Hypertrophic
Description
A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY). MeSH
Hierarchy View
Subtype Terms (2)
Cardiomyopathy, Hypertrophic, Familial
2 drugs (1 approved, 1 experimental)
Approved Indicated Drugs (1)
Phase 3 Indicated Drugs (5)
Phase 1 Indicated Drugs (5)
Other Experimental Indicated Drugs (2)
Organization Involved with Phase 4 Indications (5)
Organization Involved with Phase 3 Indications (12)
Organization Involved with Phase 2 Indications (16)
Organization Involved with Phase 1 Indications (5)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.